Cardiothoracic & vascular anesthesia
Safety of Transesophageal Echocardiography in Patients Referred for Tricuspid Valve Disease at a Center for Structural Heart Disease
Authors' conclusion
Patients with severe tricuspid regurgitation had a high prevalence of adverse events when undergoing TEE.
Study context
- Population
- Patients referred for TEE for tricuspid valve disease, July 2022–June 2023, structural heart disease center
- Participants
- 105 patients
- Outcome
- Composite of hypotension (MAP < 60 mmHg); epinephrine, norepinephrine or calcium chloride use; aborted study for clinical instability; emergent intubation; hospitalization or escalation of care post-TEE; oropharyngeal or gastrointestinal injury; or cardiac arrest
Methodological detailssingle-centre, quaternary referral center
- Single-centre
- Quaternary referral center
Main finding
As reported in the abstract
Primary composite outcome
Patients with primary outcome
32
30.5%
Observational data: associations, not effects.
Secondary outcomes
Baseline right ventricular (RV) findings in patients meeting vs not meeting the primary outcome
- Moderate to severe RV dilation
- 77% vs 53%; p = 0.022
- Moderately to severely decreased RV function
- 48% vs 25%; p = 0.023
- RV fractional area change (lower in patients meeting primary outcome)
- 37.9% vs 29.8%; p = 0.003
- Tricuspid annular plane systolic excursion (lower in patients meeting primary outcome)
- 1.84 cm vs 1.45 cm; p = 0.002
Safety
Components of the primary outcome
- Cardiac arrest
- 2.9% (3/105)
- Hypotension (MAP < 60 mmHg)
- 30
- Hospitalization after TEE
- 7
- Oropharyngeal or gastrointestinal injury
- 0
Original publication
Safety of Transesophageal Echocardiography in Patients Referred for Tricuspid Valve Disease at a Center for Structural Heart Disease. J Cardiothorac Vasc Anesth. Published 26 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →